DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Posição atual:
>
> This Story


Início de uma sessão ou Registo to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

More Magazine Features

A dose of sophistication comes to CT protocols In 2018, dose optimization means getting everyone involved

Spectral CT, workflow and dose reduction drive new CT scanner and software releases

Proton therapy comes to New York City: behind the scenes at the NYPC The construction, equipment and partnerships that make up the cutting-edge facility

Radiation shielding: ways to save and things to consider Shielding decisions should not be made lightly

The MR patient experience Technologists, effective distractions and advanced MR tech are improving patient comfort

See All Magazine Features  

Molecular Imaging Homepage

GE to provide training to at least 140 Kenyan radiographers Partnering with Society of Radiography in Kenya

NorthStar, Shine in line for federal funding Bringing $20 million in additional funding to domestic moly-99 in the US

Adel Abdullah and Aaron Hargrave Positron appoints president and vice president

Theranostics – Nuclear medicine´s fountain of youth Combining therapeutics with diagnostics, opportunities and challenges

New House bill calls for change in CMS definition of radiopharmaceuticals Reimburse separately instead of as bundled payment

Cerveau Technologies partners with Ionis Pharmaceuticals Use of PET agent, [F-18]MK-6240

New PET imaging method may yield benefits over FDG for detecting certain cancers Gallium-68-labeled FAPI tracer yields promising results

Dr. David Wong Professor recognized for contributions to PET and Theranostics

SVSR unveils Siemens Horizon PET/CT trailer Putting a small and powerful scanner on a coach

Philips to manage medical imaging equipment for Aussie providers for 20 years First-of-its-kind partnership in Australia and ASEAN Pacific region

Are bundled payments hurting nuclear medicine access and innovation?

por Lauren Dubinsky , Senior Reporter
Bundled payments are intended to lower healthcare spending and achieve value-based care, but what happens when the reimbursement is a fraction of the cost to the provider?

This is a problem being faced concerning many radiopharmaceuticals today, and some experts believe that the consequences extend beyond patients receiving compromised care to actually damaging the adoption and development of better, emerging tracers.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



Since different radiopharmaceuticals can cost anywhere between $20 and $3,000 per unit dose, bundling them into the same category means a facility will lose money performing an exam with expensive “supplies”.

For instance, if there is an average bundle package of $700 for a certain procedure and the radiopharmaceutical costs $1,200 then the hospital loses $500. And that doesn’t even factor in the cost of technology, salaries and radiologist reading fees.

Dr. Munir Ghesani
“In this model, they are not able to account for huge differences in the costs from one radiopharmaceutical to another,” said Dr. Munir Ghesani, associate professor of radiology at NYU Langone Medical Center, and a member of the government relations committee at the SNMMI. “As a result, a lot of physicians do not use the expensive radiopharmaceuticals.”

Although technically drugs, CMS classifies radiopharmaceuticals as supplies so it can incorporate them into bundled payments under Ambulatory Payment Classifications (APCs) in the Medicare Hospital Outpatient Prospective Payment System (OPPS).

“The reason for that is cost savings,” said Ghesani. “When you bundle things together, it usually saves money.”

And generally speaking, bundled payments are a great thing, he added, but he and his peers believe packaging radiopharmaceuticals with procedures may be doing more harm than good.

In addition to preventing Medicare patients from receiving the nuclear medicine procedures they require, the current reimbursement situation may also hinder innovation because companies don’t want to spend money on the development of a radiopharmaceutical that hospitals won’t purchase.

“That is a major concern and part of the reason why some of the major players in this field have backed out of developing radiopharmaceuticals,” said Ghesani.
  Pages: 1 - 2 - 3 >>

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente a Sua Perceção da Marca
Leilões + Vendas Privadas
Comece
O mais melhor preço
Comprar Equipamento/Peças
Encontre
O preço o mais baixo
Notícia diária
Leia
A notícia a mais atrasada
Diretório
Browse tudo
DOTmed Usuários
Ética no DOTmed
Veja o nosso
Programa das éticas
O ouro parte o programa do vendedor
Receba PH
Pedidos
Programa do negociante do serviço do ouro
Receba RFP/PS
Pedidos
Fornecedores de Healthcare
Veja tudo
Ferramentas de HCP
Trabalhos/Treinamento
Achado/suficiência
Um trabalho
Parts Hunter +EasyPay
Comece as peças
Citações
Certificado recentemente
Vista recentemente
Usuários certificados
Recentemente Rated
Vista recentemente
Usuários certificados
Central Rental
Equipamento do aluguel
Para menos
Vender Equipamentos/Peças
Comece
A maioria de dinheiro
Preste serviços de manutenção ao Forum dos técnicos
Ajuda do achado
E conselho
Simples RFP
Comece o equipamento
Citações
Mostra de comércio virtual
Serviço do achado
Para o equipamento
O acesso e o uso deste local são sujeitos aos termos e às condições do nosso OBSERVAÇÃO LEGAL & OBSERVAÇÃO DA PRIVACIDADE
Propriedade de e proprietário DOTmeda .com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
TODOS OS DIREITOS RESERVADOS